Tags: Alzheimer's/Dementia | drug | Alzheimers | Reiman | plaques | aducanumab

New Drug Shows Promise Against Alzheimer's

New Drug Shows Promise Against Alzheimer's

(Copyright iStock)

Thursday, 01 September 2016 03:08 PM

An experimental drug called aducanumab shows promise in treating Alzheimer's disease, researchers report.

A small clinical trial showed that it significantly reduced toxic plaques in the brains of 165 patients with early-stage Alzheimer's disease, National Public Radio reported Wednesday.

The findings, published in the journal Nature, suggest the drug may slow the loss of memory and thinking in Alzheimer's patients.

"If that hint of a clinical benefit is confirmed, it would be a game changer in the fight against Alzheimer's disease," said Dr. Eric Reiman, executive director of the Banner Alzheimer's Institute in Phoenix, NPR reported.

He wrote a commentary that accompanied the study. Much larger clinical trials are needed to confirm whether the drug actually slows Alzheimer's disease, Reiman said.

Two much larger studies of aducanumab have already been started by drug maker Biogen Inc. Those trials will include 2,700 patients, with results not expected for several years, NPR reported.

© HealthDay

   
1Like our page
2Share
Health-News
An experimental drug called aducanumab shows promise in treating Alzheimer's disease, researchers report. A small clinical trial showed that it significantly reduced toxic plaques in the brains of 165 patients with early-stage Alzheimer's disease, National Public Radio...
drug, Alzheimers, Reiman, plaques, aducanumab
152
2016-08-01
Thursday, 01 September 2016 03:08 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved